Clinical Trial

Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study

Study acronym: SYMON II
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to validate a pre-defined IL-6 concentration cutoff that predicts 28-day mortality in patients who are admitted or are intended to be admitted to the ICU diagnosed with sepsis or septic shock.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-10-21; most recent amendment 2026-02-02.
Status change: Not Yet Recruiting → Recruiting 2024-11-25
Trial Details
NCT Number NCT06654895
Lead Sponsor Bluejay Diagnostics, Inc.
Conditions Sepsis, Septic Shock
Enrollment 700 participants
Start Date 2024-11-12
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-03